|
CDC26 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.354760E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.137800E-02 |
| Normal-vs-Stage2 |
2.375800E-03 |
| Normal-vs-Stage3 |
1.92349999994512E-06 |
| Normal-vs-Stage4 |
2.977800E-04 |
| Stage1-vs-Stage2 |
4.355600E-02 |
| Stage1-vs-Stage3 |
1.794810E-04 |
| Stage1-vs-Stage4 |
2.742700E-03 |
| Stage2-vs-Stage3 |
3.220400E-01 |
| Stage2-vs-Stage4 |
5.873800E-01 |
| Stage3-vs-Stage4 |
6.525600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.574000E-04 |
| Normal-vs-AfricanAmerican |
8.03719999999952E-05 |
| Normal-vs-Asian |
8.511000E-01 |
| Caucasian-vs-AfricanAmerican |
6.863900E-02 |
| Caucasian-vs-Asian |
2.677000E-01 |
| AfricanAmerican-vs-Asian |
6.019600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50765999999969E-05 |
| Normal-vs-Female |
5.618200E-02 |
| Male-vs-Female |
1.213770E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.419700E-02 |
| Normal-vs-Age(41-60Yrs) |
5.695200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.003760E-04 |
| Normal-vs-Age(81-100Yrs) |
8.528400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.103600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.086000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.020600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.092400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.312400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.053800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.754400E-01 |
| Normal-vs-Grade 2 |
6.063800E-02 |
| Normal-vs-Grade 3 |
1.85489999999788E-05 |
| Normal-vs-Grade 4 |
2.23400000000096E-05 |
| Grade 1-vs-Grade 2 |
1.834610E-01 |
| Grade 1-vs-Grade 3 |
1.997680E-02 |
| Grade 1-vs-Grade 4 |
5.242300E-04 |
| Grade 2-vs-Grade 3 |
5.703500E-03 |
| Grade 2-vs-Grade 4 |
1.283780E-03 |
| Grade 3-vs-Grade 4 |
2.054200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.825000E-01 |
| Normal-vs-ccB subtype |
9.29819998773951E-10 |
| ccA subtype-vs-ccB subtype |
2.05169214950729E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.89409999999635E-05 |
| Normal-vs-N1 |
7.019600E-02 |
| N0-vs-N1 |
6.621000E-01 |
|
|
